Clinical trial
Endostatin and Other Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
NCT00668473 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endostatin and Other Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
- Lead sponsor
- University of Michigan
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- January 31, 2012
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic sclerosis